AXA

New appointments to back the renewed strategy

22/02/21 -"Since his arrival, Thomas Buberl has been injecting new blood into Axa’s management. The possible arrival of Ramon Fernandez, as a member of the Board of Directors, would be good news. The ..."

PDF page sample
Pages
53
Language
English
Published on
22/02/21
Download
You may also be interested by these reports :
13/11/25
Talanx reported strong 3Q25 results, above consensus expectations, and raised its net profit guidance for both FY25 and FY26. We believe the new ...
12/11/25
Munich Re delivered a mixed set of 3Q25 results. On the positive side, net profit reached €1,997m, 3.7% above consensus, more than double the 3Q24 ...
12/11/25
Munich Re reported a strong set of 3Q25 results, with net profit of c. €2bn, driven by the P&C reinsurance business, and supported by low large ...
11/11/25
Hannover Re delivered strong 3Q25 results, despite adding further prudence in both P&C and L&H during the quarter and opportunistically realising ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO